Additive Manufacturing in Medical Devices: From Surgical Guides to Implants
- Mar 11
- 4 min read
Medicine is one of the highest-stakes environments for additive manufacturing — and one of the most rewarding. The ability to produce patient-specific geometry, biocompatible materials, and complex internal structures has opened applications that were literally impossible before 3D printing existed. From titanium spinal implants to clear aligner trays, additive manufacturing is embedded in modern medical device production.
Patient-Specific Implants: The Titanium Revolution
Titanium additive manufacturing (DMLS and EBM) has transformed orthopaedic implant design. The key breakthrough is the ability to print porous lattice structures on implant surfaces that replicate the mechanical compliance of bone and provide a scaffold for osseointegration — biological ingrowth of bone tissue into the implant surface. Traditional machined implants have smooth surfaces that rely on cement or press-fit for fixation. Printed implants with engineered porosity achieve superior long-term fixation through direct bone ingrowth.
Stryker's Tritanium product line, printed using EBM titanium, is now implanted in millions of patients globally across hip, knee, and spinal applications. The trabecular-like porous structure on the implant surface mimics cancellous bone architecture, with pore sizes of 300–900 microns optimised for cell adhesion and vascular in-growth. This isn't possible with machining or casting — it's an additive-only capability.
Patient-specific implants take personalisation further. For complex craniofacial reconstruction, tumour resection defects, or unusual anatomy, implants can be designed directly from patient CT or MRI scans and printed as exact anatomical fits. Custom cranial plates, mandibular implants, and acetabular cups for complex revision surgery are all produced this way, eliminating the intraoperative fitting time and complications associated with using standard-size implants in non-standard anatomy.
Surgical Planning Models and Guides
SLA and FDM are the dominant technologies for surgical planning models and patient-specific cutting guides. Anatomical models printed from patient scans allow surgeons to physically rehearse complex procedures before entering the operating theatre — reducing operative time, improving outcomes, and supporting consent conversations with patients who benefit from seeing a physical representation of their own anatomy.
Surgical cutting guides are jigs designed to fit precisely on a specific patient's bone and guide saw cuts or drill trajectories during orthopaedic or craniofacial surgery. A guide printed from a patient's CT scan eliminates reliance on intraoperative judgement for positioning cuts, dramatically improving reproducibility. Patient-specific guides for total knee arthroplasty, tibial osteotomies, and spinal pedicle screw placement are in routine clinical use at major orthopaedic centres.
Dental: The Largest Volume Additive Manufacturing Medical Application
By volume, dental is the largest medical application of additive manufacturing globally. SLA and DLP printing of dental models, surgical guides, splints, denture bases, and temporary restorations has transformed the dental laboratory workflow. Digital intraoral scanning combined with CAD design and SLA printing produces study models, surgical implant guides, and prosthodontic components faster and more accurately than traditional analogue methods.
Clear aligner orthodontics (Invisalign being the best-known example) is entirely enabled by additive manufacturing. Each patient requires a series of custom aligner trays, each slightly different in geometry to progressively move teeth. These trays are thermoformed over 3D printed models — millions of which are printed daily at Align Technology's facilities. The economics of producing millions of unique, patient-specific parts at this scale would be impossible with any conventional manufacturing process.
Medical Regulation: FDA, CE, and the ISO 13485 Framework
Medical additive manufacturing operates within a rigorous regulatory framework. In the United States, 3D printed medical devices are regulated by the FDA under 21 CFR Parts 820 and 801 — the same Quality System Regulation framework that applies to all medical device manufacturing. The FDA published specific guidance on technical considerations for additive manufacturing of medical devices in 2017, covering design controls, software validation, material characterisation, and post-processing requirements.
In Europe, medical devices are regulated under MDR 2017/745, with CE marking required for market access. ISO 13485 (Quality Management Systems for medical devices) is the standard framework for medical device manufacturers, and its requirements apply equally to additive manufacturing production as to conventional processes. Biocompatibility testing under ISO 10993 is required for any material that comes into contact with patients.
Emerging Applications: Bioprinting and Drug Delivery
Beyond current production applications, the frontier of medical additive manufacturing includes bioprinting — the deposition of living cells in a scaffold matrix to create tissue constructs — and personalised drug delivery. Bioprinting remains predominantly at the research stage, but organoids and tissue models are already in use for drug screening. Aprecia's SPRITAM, approved by the FDA in 2015, was the first 3D printed drug — a precisely porous tablet that disintegrates rapidly for patients with difficulty swallowing. The convergence of pharmaceutical and additive manufacturing is accelerating, with personalised dosing and combination drug products representing near-term clinical opportunities.
The Outlook for Medical Additive Manufacturing
Medical is the sector where additive manufacturing's defining characteristics — patient specificity, geometric freedom, and on-demand production — align most directly with clinical need. As manufacturing qualification frameworks mature, material portfolios expand, and digital imaging workflows become more seamlessly integrated with production, the volume and clinical significance of 3D printed medical products will increase substantially. The transition from prototyping to production is already complete in dental and orthopaedics. Surgical instruments, hearing devices, and pharmaceutical applications are following closely behind.
